VRDN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.65%

Insider Buying (Last 12 Months): $30,616,312.00

Insider Selling (Last 12 Months): $0.00

Viridian Therapeutics Insider Trading History Chart

Viridian Therapeutics Share Price & Price History

^$14.44

▼ -0.23 (-1.57%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Viridian Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/27/2024	Stephen F. Mahoney	CEO	Buy	21,400	$23.33	$499,262.00	21,400
9/27/2024	Thomas W Beetham	COO	Buy	5,000	$23.41	$117,050.00	6,000
9/13/2024	Fairmount Funds Management Llc	Director	Buy	1,600,000	$18.75	$30,000,000.00	3,445,813
1/22/2024	Fairmount Funds Management Llc	Director	Buy	476,190	$21.00	$9,999,990.00	1,839,954
6/15/2023	Lara Meisner	Insider	Sell	2,269	$28.02	$63,577.38	29,971
6/5/2023	Lara Meisner	Insider	Sell	499	$25.03	$12,489.97	29,971
6/2/2023	Lara Meisner	Insider	Sell	1,875	$24.21	$45,393.75	29,971
4/12/2023	Scott Dunseth Myers	CEO	Buy	4,000	$25.37	$101,480.00	259,500
3/13/2023	Scott Dunseth Myers	CEO	Buy	5,500	$29.15	$160,325.00	255,500
3/9/2023	Lara Meisner	General Counsel	Sell	29,971	$29.07	$871,256.97
2/2/2023	Jonathan Violin	Insider	Sell	50,000	$36.80	$1,840,000.00	430,905
1/23/2023	Lara Meisner	General Counsel	Sell	6,843	$35.66	$244,021.38
1/17/2023	Barrett Katz	insider	Sell	24,853	$37.21	$924,780.13
1/13/2023	Barrett Katz	insider	Sell	4,147	$37.01	$153,480.47
1/10/2023	Barrett Katz	insider	Sell	47,377	$35.30	$1,672,408.10
12/20/2022	Lara Meisner	General Counsel	Sell	600	$28.07	$16,842.00
12/16/2022	Lara Meisner	General Counsel	Sell	1,297	$28.44	$36,886.68
12/14/2022	Lara Meisner	General Counsel	Sell	15,656	$28.12	$440,246.72
12/12/2022	Lara Meisner	General Counsel	Sell	600	$28.05	$16,830.00
11/15/2022	Lara Meisner	General Counsel	Sell	8,125	$22.05	$179,156.25
8/17/2022	Fairmount Funds Management Llc	Director	Buy	425,531	$23.50	$9,999,978.50	1,363,764
6/1/2022	Jonathan Violin	Insider	Sell	30,000	$12.20	$366,000.00	480,905
5/2/2022	Jonathan Violin	CEO	Sell	30,000	$13.04	$391,200.00	510,905
4/4/2022	Jonathan Violin	Insider	Sell	3,600	$18.93	$68,148.00	540,905
4/1/2022	Jonathan Violin	Insider	Sell	26,400	$18.92	$499,488.00	540,905

See Full Table

SEC Filings (Institutional Ownership Changes) for Viridian Therapeutics (NASDAQ:VRDN)

Institutional Buying and Selling by Quarter

Viridian Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	224,484	$4.30M	0.0%	-4.9%	0.275%
3/18/2025	California State Teachers Retirement System	54,710	$1.05M	0.0%	+18.0%	0.067%
2/18/2025	Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.	423,272	$8.11M	1.0%	-33.1%	0.534%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	115,782	$2.22M	0.0%	+29.4%	0.146%
2/17/2025	Woodline Partners LP	813,647	$15.60M	0.1%	-0.7%	1.027%
2/17/2025	Soleus Capital Management L.P.	45,500	$0.87M	0.1%	-52.1%	0.057%
2/17/2025	Squarepoint Ops LLC	33,251	$0.64M	0.0%	-23.7%	0.042%
2/17/2025	Two Sigma Advisers LP	335,569	$6.43M	0.0%	-24.6%	0.424%
2/17/2025	Two Sigma Investments LP	424,537	$8.14M	0.0%	-11.9%	0.536%
2/17/2025	Tang Capital Management LLC	2,492,925	$47.79M	3.2%	+11.1%	3.147%
2/17/2025	Rafferty Asset Management LLC	172,960	$3.32M	0.0%	+90.8%	0.218%
2/17/2025	ProShare Advisors LLC	20,584	$0.40M	0.0%	+74.1%	0.026%
2/17/2025	Paradigm Biocapital Advisors LP	1,820,079	$34.89M	1.2%	-37.1%	2.298%
2/17/2025	Parkman Healthcare Partners LLC	1,087,634	$20.85M	2.8%	+155.9%	1.373%
2/17/2025	Nuveen Asset Management LLC	681,012	$13.06M	0.0%	+198.2%	0.860%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	44,600	$0.86M	0.1%	N/A	0.056%
2/17/2025	Millennium Management LLC	365,972	$7.02M	0.0%	-45.2%	0.462%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	48,400	$0.93M	0.0%	+40.7%	0.061%
2/17/2025	Graham Capital Management L.P.	12,900	$0.25M	0.0%	-10.6%	0.016%
2/17/2025	D. E. Shaw & Co. Inc.	442,070	$8.47M	0.0%	+220.2%	0.558%
2/17/2025	Deutsche Bank AG	402,874	$7.72M	0.0%	+6.1%	0.509%
2/17/2025	Driehaus Capital Management LLC	1,875,876	$35.96M	0.3%	-5.8%	2.368%
2/17/2025	Deep Track Capital LP	4,522,741	$86.70M	3.2%	+20.6%	5.710%
2/17/2025	Concentric Capital Strategies LP	88,527	$1.70M	0.1%	N/A	0.112%
2/17/2025	Corton Capital Inc.	12,702	$0.24M	0.1%	-19.6%	0.016%
2/17/2025	Crestline Management LP	200,857	$3.85M	0.1%	+31.7%	0.254%
2/17/2025	Cutter Capital Management LP	628,677	$12.05M	4.9%	+21.2%	0.794%
2/17/2025	Braidwell LP	34,094	$0.65M	0.0%	N/A	0.043%
2/17/2025	Brevan Howard Capital Management LP	13,473	$0.26M	0.0%	N/A	0.017%
2/17/2025	Balyasny Asset Management L.P.	130,721	$2.51M	0.0%	-61.4%	0.165%
2/17/2025	Bayesian Capital Management LP	25,700	$0.49M	0.1%	+99.2%	0.032%
2/17/2025	Bank of America Corp DE	247,107	$4.74M	0.0%	+36.5%	0.312%
2/17/2025	BNP Paribas Financial Markets	203,853	$3.91M	0.0%	N/A	0.257%
2/17/2025	Ameriprise Financial Inc.	48,793	$0.94M	0.0%	+16.2%	0.062%
2/17/2025	Algert Global LLC	96,393	$1.85M	0.0%	-16.1%	0.122%
2/14/2025	Novo Holdings A S	2,250,000	$43.13M	2.6%	-5.7%	2.841%
2/14/2025	Schonfeld Strategic Advisors LLC	670,600	$12.86M	0.1%	-12.1%	0.847%
2/14/2025	Foresite Capital Management VI LLC	1,974	$38K	0.0%	N/A	0.002%
2/14/2025	Northern Trust Corp	694,142	$13.31M	0.0%	+19.3%	0.876%
2/14/2025	The Manufacturers Life Insurance Company	49,720	$0.95M	0.0%	+101.0%	0.063%
2/14/2025	Tudor Investment Corp ET AL	38,367	$0.74M	0.0%	+3.0%	0.048%
2/14/2025	Artia Global Partners LP	100,000	$1.92M	0.7%	N/A	0.126%
2/14/2025	Virtus ETF Advisers LLC	3,952	$76K	0.0%	-43.6%	0.005%
2/14/2025	Nebula Research & Development LLC	17,132	$0.33M	0.0%	N/A	0.022%
2/14/2025	Lord Abbett & CO. LLC	459,588	$8.81M	0.0%	+17.3%	0.580%
2/14/2025	Voya Investment Management LLC	21,397	$0.41M	0.0%	+5.1%	0.027%
2/14/2025	Adage Capital Partners GP L.L.C.	1,670,000	$32.01M	0.1%	+38.6%	2.108%
2/14/2025	Price T Rowe Associates Inc. MD	1,326,811	$25.44M	0.0%	+2,847.7%	1.675%
2/14/2025	Dark Forest Capital Management LP	13,285	$0.26M	0.0%	N/A	0.017%
2/14/2025	Silverarc Capital Management LLC	100,000	$1.92M	0.4%	N/A	0.126%
2/14/2025	Diadema Partners LP	49,478	$0.95M	0.4%	N/A	0.062%
2/14/2025	Eversept Partners LP	779,998	$14.95M	1.3%	+12.8%	0.985%
2/14/2025	J. Safra Sarasin Holding AG	36,453	$0.70M	0.0%	N/A	0.046%
2/14/2025	Vivo Capital LLC	982,576	$18.84M	2.1%	-41.5%	1.240%
2/14/2025	Tower Research Capital LLC TRC	34,172	$0.66M	0.0%	+824.3%	0.043%
2/14/2025	MetLife Investment Management LLC	44,295	$0.85M	0.0%	+21.8%	0.056%
2/14/2025	Dimensional Fund Advisors LP	55,924	$1.07M	0.0%	-82.9%	0.071%
2/13/2025	Farringdon Capital Ltd.	17,152	$0.33M	0.1%	N/A	0.022%
2/13/2025	Affinity Asset Advisors LLC	159,614	$3.06M	0.4%	-69.6%	0.202%
2/13/2025	XTX Topco Ltd	22,972	$0.44M	0.0%	N/A	0.029%
2/13/2025	Barclays PLC	157,860	$3.03M	0.0%	+25.9%	0.199%
2/13/2025	Summit Investment Advisors Inc.	7,646	$0.15M	0.1%	+24.7%	0.010%
2/13/2025	Raymond James Financial Inc.	313,787	$6.02M	0.0%	N/A	0.396%
2/13/2025	Renaissance Technologies LLC	371,200	$7.12M	0.0%	+522.8%	0.469%
2/13/2025	Legal & General Group Plc	60,202	$1.15M	0.0%	+8.4%	0.076%
2/13/2025	Invesco Ltd.	33,099	$0.64M	0.0%	+59.5%	0.042%
2/13/2025	ADAR1 Capital Management LLC	26,000	$0.50M	0.1%	+182.4%	0.033%
2/13/2025	FMR LLC	11,881,912	$227.78M	0.0%	+6.2%	15.001%
2/13/2025	Russell Investments Group Ltd.	379,596	$7.28M	0.0%	-14.2%	0.479%
2/12/2025	ExodusPoint Capital Management LP	25,724	$0.49M	0.0%	N/A	0.032%
2/12/2025	Bryce Point Capital LLC	44,063	$0.85M	0.2%	N/A	0.056%
2/12/2025	Knott David M Jr	25,000	$0.48M	0.2%	N/A	0.032%
2/12/2025	Trexquant Investment LP	120,065	$2.30M	0.0%	-15.8%	0.152%
2/12/2025	Geode Capital Management LLC	1,658,980	$31.81M	0.0%	+11.1%	2.094%
2/12/2025	Alliancebernstein L.P.	2,286,994	$43.84M	0.0%	+3.8%	2.887%
2/12/2025	Wellington Management Group LLP	224,484	$4.30M	0.0%	-4.9%	0.283%
2/12/2025	Pictet Asset Management Holding SA	1,248,721	$23.94M	0.0%	+21.8%	1.576%
2/12/2025	Loomis Sayles & Co. L P	1,400,381	$26.85M	2.9%	N/A	1.768%
2/12/2025	BIT Capital GmbH	285,954	$5.48M	0.4%	+239.8%	0.361%
2/12/2025	JPMorgan Chase & Co.	304,334	$5.83M	0.0%	-24.0%	0.384%
2/11/2025	Corebridge Financial Inc.	36,336	$0.70M	0.0%	+8.6%	0.046%
2/11/2025	Vanguard Group Inc.	4,595,049	$88.09M	0.0%	+4.0%	5.801%
2/11/2025	KLP Kapitalforvaltning AS	11,400	$0.22M	0.0%	N/A	0.014%
2/11/2025	American Century Companies Inc.	113,562	$2.18M	0.0%	+304.9%	0.143%
2/11/2025	Quantbot Technologies LP	8,575	$0.16M	0.0%	N/A	0.011%
2/11/2025	Yiheng Capital Management L.P.	750,261	$14.38M	0.6%	-11.5%	0.947%
2/11/2025	DCF Advisers LLC	29,750	$0.57M	0.3%	+105.2%	0.038%
2/11/2025	Teacher Retirement System of Texas	17,015	$0.33M	0.0%	+21.6%	0.021%
2/10/2025	Swiss National Bank	112,600	$2.16M	0.0%	+4.2%	0.142%
2/7/2025	AlphaQuest LLC	2,795	$54K	0.0%	+119.0%	0.004%
2/7/2025	E Fund Management Co. Ltd.	12,236	$0.24M	0.0%	N/A	0.015%
2/7/2025	Candriam S.C.A.	731,221	$14.02M	0.1%	-2.5%	0.923%
2/6/2025	Raymond James Financial Inc.	313,787	$6.02M	0.0%	N/A	0.396%
2/6/2025	Arizona State Retirement System	16,596	$0.32M	0.0%	+19.5%	0.021%
2/6/2025	Victory Capital Management Inc.	410,440	$7.87M	0.0%	N/A	0.518%
2/6/2025	Charles Schwab Investment Management Inc.	575,070	$11.02M	0.0%	+11.4%	0.726%
2/5/2025	Fisher Asset Management LLC	518,027	$9.93M	0.0%	+4.7%	0.654%
2/4/2025	Bank of New York Mellon Corp	196,522	$3.77M	0.0%	+15.0%	0.248%
1/31/2025	Rice Hall James & Associates LLC	53,375	$1.02M	0.1%	N/A	0.067%
1/31/2025	Principal Financial Group Inc.	178,444	$3.42M	0.0%	+3.3%	0.225%

Data available starting January 2016

See Full Table

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $14.44

$14.19

$14.74

50 Day Range

MA: $16.75

$14.16

$20.08

52 Week Range

Now: $14.44

$11.40

$27.20

Volume

594,046 shs

Average Volume

1,172,191 shs

Market Capitalization

$1.18 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Who are the company insiders with the largest holdings of Viridian Therapeutics?: Viridian Therapeutics' top insider investors include:
Fairmount Funds Management Llc (Director)
Scott Dunseth Myers (CEO)
Lara Meisner (Insider)
Stephen F Mahoney (CEO)
Thomas W Beetham (COO)
Learn More about top insider investors at Viridian Therapeutics.
Who are the major institutional investors of Viridian Therapeutics?: Viridian Therapeutics' top institutional shareholders include:
FMR LLC — 15.00%
Vanguard Group Inc. — 5.80%
Deep Track Capital LP — 5.71%
Tang Capital Management LLC — 3.15%
Alliancebernstein L.P. — 2.89%
Novo Holdings A S — 2.84%
Learn More about top institutional investors of Viridian Therapeutics stock.
Which major investors are selling Viridian Therapeutics stock?: During the last quarter, VRDN stock was sold by these institutional investors:
Paradigm Biocapital Advisors LP
Vivo Capital LLC
Affinity Asset Advisors LLC
Millennium Management LLC
Dimensional Fund Advisors LP
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
Balyasny Asset Management L.P.
Novo Holdings A S
Which major investors are buying Viridian Therapeutics stock?: Within the previous quarter, VRDN stock was acquired by institutional investors including:
Loomis Sayles & Co. L P
Price T Rowe Associates Inc. MD
Deep Track Capital LP
FMR LLC
Parkman Healthcare Partners LLC
Adage Capital Partners GP L.L.C.
Nuveen Asset Management LLC
Victory Capital Management Inc.
In the previous year, these company insiders have bought Viridian Therapeutics stock:
Fairmount Funds Management Llc (Director)
Scott Dunseth Myers (CEO)
Lara Meisner (Insider)
Stephen F Mahoney (CEO)
Learn More investors buying Viridian Therapeutics stock.